Prescription ·Strong evidence ·Reviewed May 2026
Cefpodoxime is an oral third-generation cephalosporin antibiotic administered as the prodrug cefpodoxime proxetil, which is hydrolyzed to active cefpodoxime during intestinal absorption. It is used for community-acquired respiratory tract infections, acute otitis media, pharyngitis, uncomplicated skin infections, and uncomplicated urinary tract infections. Like other third-generation agents it offers extended Gram-negative coverage and stability against many beta-lactamases compared with earlier cephalosporins.
The bottom line
Evidence rating strong. Most-documented uses: community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis. 3 sources indexed (1992–2010), with 6 interaction records on file.
Core mechanism
Cefpodoxime is a beta-lactam antibiotic that exerts bactericidal activity by binding to and inhibiting penicillin-binding proteins (PBPs), the transpeptidase and carboxypeptidase enzymes responsible for cross-linking peptidoglycan strands in the bacterial cell wall. Disruption of cell wall synthesis leaves the wall structurally weak, leading to autolysis and cell death, particularly in actively dividing organisms. Its beta-lactam ring and oximino side chain confer relative stability to many plasmid-mediated beta-lactamases, extending activity against Gram-negative pathogens, though it remains susceptible to extended-spectrum beta-lactamases (ESBLs) and is not active against Pseudomonas aeruginosa, enterococci, or methicillin-resistant staphylococci.1,2
Tablet absorption is enhanced by food, so cefpodoxime proxetil tablets should be taken with a meal; the oral suspension is not affected by food. Absorption requires gastric acid, so antacids and H2-blockers reduce bioavailability and should be separated in time. The prodrug is de-esterified to active cefpodoxime during gastrointestinal absorption.
Nutrients this medication can lower over time, and what to replace.
As a broad-spectrum oral antibiotic, cefpodoxime suppresses the colonic bacteria that synthesize menaquinones (vitamin K2), which can reduce the endogenous vitamin K supply. Unlike some cephalosporins (for example cefoperazone or cefamandole), cefpodoxime lacks the N-methylthiotetrazole (NMTT) side chain, so it does not directly inhibit vitamin K epoxide reductase; the effect is therefore limited to gut-flora disruption and is usually clinically minor except during prolonged therapy or in patients with poor dietary intake, malabsorption, or concurrent warfarin use.
Cefpodoxime can suppress or kill bacterial probiotic organisms if taken at the same time, although selected probiotics may lower antibiotic-associated diarrhea risk.
Recommendation: Separate probiotic doses from the antibiotic by at least 2 hours when feasible; avoid probiotic use in severely immunocompromised patients or patients with central lines unless clinician-directed.
Prolonged Cefpodoxime therapy can contribute to reduced vitamin K status in susceptible patients by altering gut flora, with higher concern in poor intake, malabsorption, liver disease, or warfarin use.
Recommendation: Do not self-treat bleeding or INR changes. Monitor for bruising or bleeding and coordinate vitamin K or anticoagulant changes with the prescriber.
Oral iron supplements may reduce the absorption of cefpodoxime. Beyond simple chelation, cefpodoxime proxetil requires an acidic gastric environment for adequate dissolution and absorption, and concurrent intake with iron salts (which are themselves best taken on an empty/acidic stomach) raises the practical risk of reduced antibiotic exposure if dosing is not separated. Lower cefpodoxime serum levels can compromise treatment of respiratory and urinary infections.
Recommendation: Separate doses to preserve antibiotic efficacy. Take cefpodoxime at least 2 hours before or after an iron supplement. Continue iron as prescribed but stagger the timing for the duration of the antibiotic course.
Calcium supplements and calcium-containing antacids may reduce cefpodoxime absorption. Cefpodoxime proxetil depends on gastric acidity for adequate dissolution, and calcium carbonate antacids that raise gastric pH can meaningfully blunt absorption. Polyvalent calcium cations may also bind the drug in the gut.
Recommendation: Separate dosing by at least 2 hours. Take cefpodoxime first, then the calcium supplement or calcium-based antacid afterward. Avoid taking calcium carbonate antacids around the same time as the antibiotic.
Magnesium-containing supplements and antacids can reduce cefpodoxime absorption. Magnesium hydroxide antacids in particular raise gastric pH, and because cefpodoxime proxetil requires gastric acidity for dissolution, co-administration can lower antibiotic bioavailability. Magnesium glycinate is a milder, well-buffered form but the timing principle still applies during an antibiotic course.
Recommendation: Separate dosing by at least 2 hours, taking cefpodoxime first. Avoid magnesium hydroxide antacids near the time of the antibiotic dose. Magnesium glycinate taken at bedtime, away from the antibiotic, is unlikely to interfere.
Oral zinc supplements may reduce cefpodoxime absorption through formation of poorly absorbed metal-drug complexes in the gut. As with other divalent cations, co-ingestion can lower the antibiotic's bioavailability and risk subtherapeutic levels.
Recommendation: Separate doses by at least 2 hours. Take cefpodoxime first, then zinc later. This is most relevant for higher-dose zinc supplements taken during a cold or for immune support while on the antibiotic.
Numbered references. Citations throughout the page link here.
Cefpodoxime exerts bactericidal activity by binding penicillin-binding proteins and is stable to many beta-lactamases, conferring extended Gram-negative activity typical of third-generation cephalosporins.
Cefpodoxime proxetil provides broad Gram-positive and Gram-negative coverage with twice-daily dosing and is effective across common community-acquired respiratory and urinary infections.
Cefpodoxime proxetil tablet absorption is enhanced in the presence of food; antacids and H2-receptor antagonists reduce peak plasma concentrations and extent of absorption.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
